NVILE forecast ·
UnitedHealth (UNH) Stock Forecast: Next 30 Days
NVILE's calibrated event-volatility distribution indicates an 80% price range of $361.87 to $441.23 for UnitedHealth Group over the next 30 days, centered around $399.58. The probability of a rise exceeding 10% is 13%, while the probability of a decline exceeding 10% is 8%. Price history alone exhibits no directional edge. Wall Street analysts maintain a bullish 12-month mean target of $476.64, supported by raised guidance, though regulatory scrutiny presents lingering tail risk.
Price now
$397.08
Nov 2, 2026
In 30 days
$399.58
NVILE forecast
Expected move
+0.6%
Range
$361.87–$441.23
What to do
- Manage exposure around the calibrated $361.87 to $441.23 boundary rather than positioning for directional breakout.Distribution models show modest directional probability with balanced distribution width.
- Monitor antitrust and Medicare Advantage policy inquiries before expanding position sizes.[5]Regulatory pressure represents an unhedged operational risk distinct from financial performance.
Why
- UNH's calibrated 80% price distribution over 30 days spans from $361.87 to $441.23, based on normal volatility conditions.
- UnitedHealth raised its full-year 2026 outlook following Q3 2026 revenue of $112.7B and operating earnings of $6.6B.[1],[6]
- Wall Street consensus maintains a 12-month average price target of $476.64, implying upside despite recent short-term price pullbacks.[7],[11]
- Management raised full-year 2026 guidance as Medicare Advantage and Optum Health operations showed improving margin execution.[1],[6]
- Medical benefit ratio improved significantly year-over-year from 89.4% to 86.7%, reflecting disciplined medical cost containment.[4],[5]
What could go wrong
How it connects
- Stephen Hemsleyserves as Chief Executive Officer ofUnitedHealth Group Inc.[1]
- Erin Wrightserves as equity research analyst atMorgan Stanley[6]
- Morgan Stanleyreiterated buy rating with $529 price target onUnitedHealth Group Inc.[6],[4]
- UBS Groupraised price target from $460 to $490 onUnitedHealth Group Inc.[4]
- UnitedHealth Group Inc.operates healthcare service provider divisionOptum Health[6]
- SECreceives regulatory filings and insider disclosure fromUnitedHealth Group Inc.[1],[3]
- FINRAmonitors daily Reg SHO short-sale transaction data ofUnitedHealth Group Inc.[2]
NVILE's track record on this page
| Made | Forecast | Actual | Result |
|---|---|---|---|
| Nov 2, 2026 | $399.58 | Due Dec 2, 2026 | Pending |
| Oct 30, 2026 | $412.07 | Due Nov 29, 2026 | Pending |
Every published call is scored when it comes due. See all results →
Sources
- 1.uhgearnings_q32026vfinal · sec.gov
- 2.UNH daily short-sale volume (FINRA) · finra.org
- 3.UNITEDHEALTH GROUP INC insider transactions (SEC Form 4) · sec.gov
- 4.UnitedHealth Pulls Back Post 52-Week High: Healthcare ETFs to Watch · theglobeandmail.com
- 5.UnitedHealth Group Inc (UNH) · morningstar.com
- 6.Top analysts are bullish on the growth potential of these 3 ... · cnbc.com
- 7.UNH Wall Street consensus: estimates, revisions, ratings, targets · finance.yahoo.com
- 8.UnitedHealth Group Incorporated (UNH) is Attracting ... · finance.yahoo.com
- 9.UnitedHealth shares look ready to extend rally · reuters.com
- 10.UNH Stock Forecast and Stock Price Prediction · stockstelegraph.com
- 11.UnitedHealth Group (UNH) Stock Forecast & Analyst Price Targets · stockanalysis.com
Questions
What is the UnitedHealth forecast for the next 30 days?
NVILE's models put UnitedHealth at about $399.58 in 30 days, +0.6% from $397.08. NVILE's calibrated event-volatility distribution indicates an 80% price range of $361.87 to $441.23 for UnitedHealth Group over the next 30 days, centered around $399.58. The probability of a rise exceeding 10% is 13%, while the probability of a decline exceeding 10% is 8%. Price history alone exhibits no directional edge. Wall Street analysts maintain a bullish 12-month mean target of $476.64, supported by raised guidance, though regulatory scrutiny presents lingering tail risk.
What price range does NVILE expect for UnitedHealth?
The forecast range is $361.87 to $441.23 over 30 days. Prices outside this range are possible; the range describes the model's scenarios, not a guarantee.
What could change the UnitedHealth outlook?
Ongoing regulatory antitrust scrutiny, coverage denial inquiries, and Medicare Advantage risk assessments remain significant fundamental headwinds. Short-term technical downside projections point to potential retreats toward $358.08 if moving average support fails.
What should investors watch or do about UnitedHealth?
Manage exposure around the calibrated $361.87 to $441.23 boundary rather than positioning for directional breakout. Monitor antitrust and Medicare Advantage policy inquiries before expanding position sizes.
How accurate are NVILE forecasts?
Every forecast NVILE publishes is scored against the real price when it comes due, and the results are listed on NVILE's public accuracy ledger.
This page is generated by NVILE's research models from public sources and market data. It is not financial advice, and forecasts can be wrong.